BlueRock Therapeutics Заявленная компания
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
читать еще
Great. The company is evolving, but seems to be managing well through the changes, which hopefully translates to a bright future at BlueRock
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
Collaboration and excitement about the corporate mission and science
Чем вы больше всего довольны в вашем пакете компенсаций?
It is fair and meets industry standards on base comp.
Что вам больше всего нравится в команде руководства?
The leadership team is supportive and transparent in communicating to the broader organization
Что приносит вам больше всего счастья/радости на работе?
The people. People are honest, transparent and collaborative. They appreciate differences and recognize that everyone has been hired to bring a unique skill set and perspective to the team. People are valued.
Каковы самые лучшие качества в вашей команде?
People are engaging and enthusiastic about what we are doing at BlueRock. BlueRock fosters a collaborative environment as we are all working towards the same goal of brining innovative cell therapies to patients
Other Employee Reviews for BlueRock Therapeutics
×